New frontiers in the biology of GLP-2

Regulatory Peptides

Volumn 90, Issue 1-3, 2000, Pages 27-32

  Lovshin, Julie ^a   Drucker, Daniel J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Enteroendocrine; Inflammatory bowel disease; Nutrition; Peptide; Small intestine; Total parenteral nutrition

Indexed keywords

ADENYLATE CYCLASE; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 2; GLUCAGON RECEPTOR; GLUCOSE TRANSPORTER; UNCLASSIFIED DRUG;

BIOSYNTHESIS; CELL REGENERATION; DRUG ACTIVITY; ENTERITIS; GLUCOSE TRANSPORT; HUMAN; INTESTINE INJURY; INTESTINE ULCER; NONHUMAN; NUTRITION; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; FORECASTING; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MICE; PEPTIDES; RATS; RECEPTORS, GLUCAGON;

EID: 0034733895     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(00)00117-8     Document Type: Review

References (56)

1. Drucker D.J. The glucagon-like peptides. Diabetes. 47:1998;159-169.
2. Holst J.J. Enteroglucagon. Annu. Rev. Physiol. 59:1997;257-291.
3. Kieffer T.J., Habener J.F. The glucagon-like peptides. Endocr. Rev. 20:1999;876-913.
4. Holst J.J. An intestinal hormone, signaling nutritional abundance, with an unusual therapeutic potential. Trends Endocrinol. Metabol. 1999;10.
5. Gleeson M.H., Bloom S.R., Polak J.M., Henry K., Dowling R.H. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut. 12:1971;773-782.
6. Stevens F.M., Flanagan R.W., O'Gorman D., Buchanan K.D. Glucagonoma syndrome demonstrating giant duodenal villi. Gut. 25:1984;784-791.
7. Dowling R.H. Small bowel adaptation and its regulation. Scand. J. Gastroenterol. 17:1982;53-74.
8. Bloom S.R., Polak J.M. The hormonal pattern of intestinal adaptation [a major role for enteroglucagon]. Scand. J. Gastroenterol. 17:1982;93-103.
9. Taylor R.G., Fuller P.J. Humoral regulation of intestinal adaptation. Bail. Clin. Endocrinol. Metabol. 8:1994;165-183.
10. Sagor G.R., Ghatei M.A., Al-Mukhtar M.Y.T., Wright N.A., Bloom S.R. Evidence for a humoral mechanism after small intestinal resection. Gastroenterology. 84:1983;902-906.
11. Besterman H.S., Adrian T.E., Mallinson C.N., Christofides N.D., Sarson D.L., Pera A., Lombardo L., Modigliani R., Bloom S.R. Gut hormone release after intestinal resection. Gut. 23:1982;854-861.
12. Goodlad R.A., Ghatei M.A., Domin J., Bloom S.R., Gregory H., Wright N.A. Plasma enteroglucagon, peptide YY and gastrin in rats deprived of luminal nutrition, and after urogastrone-EGF administration: a proliferative role for PYY in the intestinal epithelium. Experientia. 45:1989;168-169.
13. Goodlad R.A., Ghatei M.A., Bloom S.R., Wright N.A. Glucagon 1-21 reduces intestinal epithelial cell proliferation in parenterally fed rats. Exp. Physiology. 76:1991;943-949.
14. Taylor R.G., Verity K., Fuller P.J. Ileal glucagon gene expression: ontogeny and response to massive small bowel resection. Gastroenterology. 99:1990;724-729.
15. Fuller P.J., Beveridge D.J., Taylor R.G. Ileal proglucagon gene expression in the rat: characterization in intestinal adaptation using in situ hybridization. Gastroenterology. 104:1993;459-466.
16. Ulshen M.H., Hoyt E.C., Fuller C.R., Ghatei M.A., Bloom S.R., Lund P.K. Increased ileal proglucagon expression after jejunectomy is not suppressed by inhibition of bowel growth. Dig. Dis. Sci. 41:1996;677-683.
17. Drucker D.J., Ehrlich P., Asa S.L., Brubaker P.L. Induction of intestinal epithelial proliferation by glucagon-like peptide-2. Proc. Natl. Acad. Sci. USA. 93:1996;7911-7916.
18. Dhanvantari S., Seidah N.G., Brubaker P.L. Role of prohormone convertases in the tissue-specific processing of proglucagon. Mol. Endocrinol. 10:1996;342-355.
19. Rothenberg M.E., Eilertson C.D., Klein K., Mackin R.B., Noe B.D. Evidence for redundancy in propeptide/prohormone convertase activities in processing proglucagon: an antisense study. Mol. Endocrinol. 10:1996;331-341.
20. Damholt A.B., Buchan A.M., Holst J.J., Kofod H. Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2. Endocrinology. 140:1999;4800-4808.
21. Han V.K.M., Hynes M.A., Jin C., Towle A.C., Lauder J.M., Lund P.K. Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain. J. Neurosi. Res. 16:1986;97-107.
22. Drucker D.J., Asa S. Glucagon gene expression in vertebrate brain. J. Biol. Chem. 263:1988;13475-13478.
23. Brubaker P.L., Crivici A., Izzo A., Ehrlich P., Tsai C.-H., Drucker D.J. Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2. Endocrinology. 138:1997;4837-4843.
24. Tavares W., Drucker D.J., Brubaker P.L. Enzymatic and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in the rat. Am. J. Physiol. 278:(1):2000;E134-E139.
25. Drucker D.J., Shi Q., Crivici A., Sumner-Smith M., Tavares W., Hill M., Deforest L., Cooper S., Brubaker P.L. Regulation of the biological activity of glucagon-like peptide-2 by dipeptidyl peptidase IV. Nature Biotechnology. 15:1997;673-677.
26. Drucker D.J., Deforest L., Brubaker P.L. Intestinal response to growth factors administered alone or in combination with h[Gly2]-glucagon-like peptide-2. Am. J. Physiol. 273:1997;G1252-G1262.
27. Orskov C., Holst J.J. Radio-immunoassays for glucagon-like peptides-1 and -2 (GLP-1 and GLP-2). Scand. J. Clin. Lab. Invest. 47:1987;165-174.
28. Xiao Q., Boushey R.P., Drucker D.J., Brubaker P.L. Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology. 117:1999;99-105.
29. Jeppesen P.B., Hartmann B., Hansen B.S., Thulesen J., Holst J.J., Mortensen P.B. Impaired meal-stimulated glucagon-like peptide-2 response in ileal resected short bowel patients with intestinal failure. Gut. 45:1999;559-563.
30. Roberge J.N., Brubaker P.L. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology. 133:1993;233-240.
31. Rocca A.S., Brubaker P.L. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology. 140:1999;1687-1694.
32. Miazza B.M., Al-Mukhtar M.Y.T., Salmeron M., Ghatei M.A., Felce-Dachez M., Filali A., Villet R., Wright N.A., Bloom S.R., Rambaud J.-C. Hyperenteroglucagonaemia and small intestinal mucosal growth after colonic perfusion of glucose in rats. Gut. 26:1985;518-524.
33. Rountree D.B., Ulshen M.H., Selub S., Fuller C.R., Bloom S.R., Ghatei M.A., Lund P.K. Nutrient-independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection. Gastroenterology. 103:1992;462-468.
34. Xiao Q., Boushey R.P., Cino M., Drucker D.J., Brubaker P.L. Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease. Am J Physiol. 278:2000;R1057-R1063.
35. Drucker D.J., Yusta B., Boushey R.P., Deforest L., Brubaker P.L. Human [Gly2]-GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. Am. J. Physiol. 276:1999;G79-G91.
36. Tsai C.-H., Hill M., Asa S.L., Brubaker P.L., Drucker D.J. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am. J. Physiol. 273:1997;E77-E84.
37. Kato Y., Yu D., Schwartz M.Z. Glucagon-like peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo. J. Pediatr. Surg. 34:(18-20):1994;20-21.
38. Litvak D.A., Hellmich M.R., Evers B.M., Banker N.A., Townsend C.M. Jr. Glucagon-like peptide-2 is a potent growth factor for small intestine and colon. J. Gastrointest. Surg. 2:1998;146-150.
39. Litvak D.A., Evers B.M., Hellmich M.R., Townsend C.M. Jr. Enterotrophic effects of glucagon-like peptide-2 are enhanced by neurotensin. J. Gastrointest. Surg. 3:1999;432-440.
40. Thulesen J., Hartmann B., Nielsen C., Holst J.J., Poulsen S.S. Diabetic intestinal growth adaptation and glucagon-like peptide-2 in the rat: effects of dietary fibre. Gut. 45:1999;672-678.
41. Fischer K.D., Dhanvantari S., Drucker D.J., Brubaker P.L. Intestinal growth is associated with elevated levels of glucagon-like peptide-2 in diabetic rats. Am. J. Physiol. 273:1997;E815-E820.
42. Tsai C.-H., Hill M., Drucker D.J. Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am. J. Physiol. 272:1997;G662-G668.
43. Brubaker P.L., Izzo A., Hill M., Drucker D.J. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am. J. Physiol. 272:1997;E1050-E1058.
44. Kitchen P.A., Fitzgerald A.J., Goodlad R.A., Barley N.F., Ghatei M.A., Legon S., Bloom S.R., Price A., Walters J.R., Forbes A. Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 278:2000;G425-G428.
45. Wojdemann M., Wettergren A., Hartmann B., Holst J.J. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand. J. Gastroenterol. 33:1998;828-832.
46. Wojdemann M., Wettergren A., Hartmann B., Hilsted L., Holst J.J. Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2. J. Clin. Endocrinol. Metab. 84:1999;2513-2517.
47. Hoosein N.M., Gurd R.S. Human glucagon-like peptides-1 and -2 activate rat brain adenylate cyclase. FEBS Lett. 178:1984;83-86.
48. Chance W.T., Foley-Nelson T., Thomas I., Balasubramaniam A. Prevention of parenteral nutrition-induced gut hyoplasia by coinfusion of glucagon-like peptide-2. Am. J. Physiol. 273:1997;G559-G563.
49. Scott R.B., Kirk D., MacNaughton W.K., Meddings J.B. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am. J. Physiol. 275:1998;G911-G921.
50. Boushey R.P., Yusta B., Drucker D.J. Glucagon-like peptide-2 decreases mortality and reduces the severity of indomethacin-induced murien enteritis. Am. J. Physiol. 277:1999;E937-E947.
51. Prasad R., Alavi K., Schwartz M.Z. Glucagon-like peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion. J. Pediatr. Surg. 35:2000;357-359.
52. Munroe D.G., Gupta A.K., Kooshesh P., Rizkalla G., Wang H., Demchyshyn L., Yang Z.-J., Kamboj R.K., Chen H., McCallum K., Sumner-Smith M., Drucker D.J., Crivici A. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide-2. Proc. Natl. Acad. Sci. USA. 96:1999;1569-1573.
53. Campos R.V., Lee Y.C., Drucker D.J. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology. 134:1994;2156-2164.
54. Bullock B.P., Heller R.S., Habener J.F. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology. 137:1996;2968-2978.
55. Hansen L.H., Abrahamsen N., Nishimura E. Glucagon receptor mRNA distribution in rat tissues. Peptides. 16:1995;1163-1166.
56. Yusta B., Somwar R., Wang F., Munroe D., Grinstein S., Klip A., Drucker D.J. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor. J. Biol. Chem. 274:1999;30 459-30 467.